Literature DB >> 18032227

Erectile dysfunction medication use among men seeking substance abuse treatment.

Keith J Horvath1, Donald A Calsyn, Christeine Terry, Ann Cotton.   

Abstract

Few studies of erectile dysfunction (ED) medications use among heterosexual drug using or abusing men have been conducted. The aims of this study were to provide information on ED medication use prevalence, method of acquisition, and sexual effects among men seeking substance abuse treatment. A single time point cross-sectional anonymous survey was completed by 297 men over the age of 18 seeking substance abuse treatment at an outpatient clinic at a Veterans Affairs Medical Center in the Pacific Northwest. Mean age of participants was 49.7 years and 59.4% self-identified as Caucasian. Alcohol (56.7%) and cocaine (26.1%) were the primary drugs of abuse. Lifetime use of ED medications was reported by 24% (95%CI = 8.6%, 39.4%) of men. Almost 69% of ED medication users reported obtaining ED medications from a physician. Fifty-nine percent of ED medication users reported taking the medications to enhance their sexual experience rather than to treat ED, which was marginally associated with stimulant use (OR = 3.86, 95%CI = 0.96, 15.54, p = .057). These results add to an emerging recognition of the need to address the health implications of ED medication use among heterosexual drug using populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032227     DOI: 10.1300/J069v26n04_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  2 in total

1.  Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progestogen levels among intact rats.

Authors:  Amy S Kohtz; Jason J Paris; Cheryl A Frye
Journal:  Horm Behav       Date:  2010-02-19       Impact factor: 3.587

2.  Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men.

Authors:  Robert L Cook; Kathleen A McGinnis; Jeffrey H Samet; David A Fiellin; Maria C Rodriguez-Barradas; Maria C Rodriquez-Barradas; Kevin L Kraemer; Cynthia L Gibert; R Scott Braithwaite; Joseph L Goulet; Kristin Mattocks; Stephen Crystal; Adam J Gordon; Krisann K Oursler; Amy C Justice
Journal:  J Gen Intern Med       Date:  2009-11-18       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.